Saumil Sethna, PhD is an experienced professional who has worked in various scientific roles, primarily focusing on aging biology, epigenetic reprogramming, retinal diseases, and gene therapy. With a background in cell and molecular biology, Saumil has led multiple projects and collaborations to develop novel pre-clinical models and therapeutic approaches for various diseases, including AMD and inherited retinopathies. Saumil's expertise lies in gene delivery approaches, biomarker-guided strategies, and optimizing viral vectors for therapy development.
May, 2023 - present
September, 2022